CD274 and Merkel cell skin cancer: Moreover, as anti-PD-L1 immunotherapy is the newly FDA-approved treatment for metastatic MCC31, we defined the status for PD-L1 expression of the three MCC cell lines based on our optimized protocol already described in Mazel et al. Mol Oncol 201532.